| Literature DB >> 27716124 |
Sara Modig1,2, Cecilia Lenander3, Nina Viberg3,4, Patrik Midlöv3.
Abstract
BACKGROUND: There is an urgent need to improve patient safety in the area of medication treatment among the elderly. The aim of this study was to explore which improvement needs and strengths, relating to medication safety, arise from a multi-professional intervention in primary care and further to describe and follow up on the agreements for change that were established within the intervention.Entities:
Keywords: Elderly; Medication reconciliation; Medication safety; Peer-Review; Primary care; Self-assessment
Mesh:
Year: 2016 PMID: 27716124 PMCID: PMC5050592 DOI: 10.1186/s12875-016-0542-8
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Description of the different parts of the intervention model (SÄKLÄK)
| 1. Introductory meeting | Representatives from the steering committeea visited the primary care units, gave a structured introduction to the intervention model for unit managers and staff representatives, including nurses working in home care and pharmacists. The involvement of all professional categories was presented as a prerequisite for the self-assessment process. |
| 2. Structured self-assessment | The self-assessment questionnaire contained 12 questions covering areas of importance for safe use of medications in primary care, with focus on elderly patients with multiple diseases. The head of the primary care unit was responsible for the self-assessment, which was carried out together with all professional categories as well as cooperating caregivers. |
| 3. Peer review | A group of physicians, nurses and pharmacists selected by the professional organisationsb served as reviewers. For each primary care unit, a multi-professional team consisting of five to six reviewers was formed, which discussed the answered self-assessments. The primary care units were visited by a peer-review team. A document based on the questions used in the self-assessment procedure served as support for the peer review where new or updated information arising during the visit was noted. |
| 4. Written feedback and agreement for change | The peer-review team presented a written feedback report regarding their view on strengths and weaknesses, priority areas for improvement and proposed measures to be taken. Eventually, a written contract consisting of a detailed action plan was jointly produced by the primary care unit and the peer-review team. |
| 5. Follow-up seminar | A seminar for the steering committee, the reviewers and all managers at the intervention primary care units. |
| 6. Follow up on accomplishment of agreements | The agreements for change were to be followed up on 6 months after they were signed. |
aThe steering committee comprised representatives from the Swedish Association of Local Authorities and Regions (SALAR) and The Swedish National Patient Insurance Company LÖF and one delegate each from the six professional organisations listed below
bThe Swedish College of General Practice, The Swedish Pharmaceutical Society, Geriatric Medicine in Sweden, Riksföreningen för Medicinskt Ansvariga Sjuksköterskor (a Swedish association of authorized nurses), Sweden’s National Organisation of District Nurses and The Swedish Society of Clinical Pharmacology and Therapeutics
Fig. 1Illustration of the pre-defined categories for improvement need, the risen sub-categories and the identified strength categories
Type and number of agreements between the peer-review teams and the primary care units
| Main area for agreement | Number of agreements ( | Agreements not fulfilled within follow-up time ( |
|---|---|---|
| Updating the medication list (1a) | 2 | |
| Medication reconciliation (1b) | 4 | 2 |
| Medication reports (1c) | 1 | |
| Medication reviews (2a) | 10 | 2 |
| Follow-up of prescriptions (2b) | 2 | |
| Education and discussion/consensus between colleagues (2c) | 4 | 2 |
| Need for prioritisation of the frailest patients (2d) | 1 | 1 |
| Accurate medication list to rely on (3a) | 1 | |
| Information on indication and maximum dosage (3b) | 3 | 1 |
| Follow-up of mistakes (4a) | 2 | 1 |
| Follow-up of results (4b) | 1 | 2 |
| Agreements which have to be taken care of on a regional or national level | 3 | |
| General character | 4 | 1 |
aincluded in the 38 agreements
Fig. 2Policy recommendations for creating better conditions for safer drug use in Swedish primary care